Forecasts by Product Type (API, FDFs), by Primary Packaging Type (Ampoules & Vials, Glass & Plastic Bottles, Ointment Tubes, Others), by Scale of Manufacturing (Preclinical, Clinical, Commercial), by Company Size (Small Sized, Mid Sized, Large Sized), by Indication (Age-Related Macular Degeneration, Glaucoma, Uveitis, Dry Eye Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Factors Such As increasing prevalence of ophthalmic disorders and cost efficiency provided by CDMOs are driving the market growth Several important elements that support the expansion and significance of the ophthalmic drugs contract manufacturing market in the pharmaceutical industry. One of the main causes is the rising incidence of ocular conditions like age-related macular degeneration (AMD), glaucoma, cataracts, and dry eye syndrome. Pharmaceutical companies are looking for effective drug manufacturing solutions as the aging population increases and lifestyle habit changes and there is an increasing need for effective pharmaceuticals to treat and maintain these eye problems.
Additionally, by outsourcing manufacturing to the CDMOs, enables pharmaceutical businesses to concentrate on their core capabilities, such as research and marketing. This strategic partnership shortens the time of ophthalmic medications to reach the market and thereby streamlining drug development process. Modern technologies and strong quality control procedures used by CDMOs guarantee the creation of high-quality medicines that satisfy market needs and regulatory requirements.
Economical effectiveness one of the major factor driving these companies to adopt CDMO services as it takes a significant financial investment in staff, facilities, and equipment to develop new pharmaceutical goods. Companies want to reduce the overall the cost and labour costs through outsourcing to the CDMOs.
Since CDMOs already have the necessary resources and knowledge, producing drugs, it turns to be a less expensive and involves fewer risks for investors.
Complex regulatory framework may pose as challenges in the ophthalmic drugs contract manufacturing market Noncompliance with regulatory standards and poor pharmaceutical quality can have severe consequences for a business and its brand reputation. Therefore, adherence to regulatory rules is crucial in the pharmaceutical industry. Contract development and manufacturing organizations (CDMOs) face challenges in ensuring compliance with varying regulatory requirements across different regions and countries, particularly in the ophthalmic drug contract manufacturing industry. As pharmaceutical companies outsource drug manufacturing to specialized CDMOs focusing on ophthalmic products, they encounter a complex web of diverse regulatory frameworks. Each region has its distinct guidelines, standards, and procedures governing various aspects of ophthalmic drug manufacturing and distribution. This includes quality control, safety assessments, and labelling, packaging, and distribution practices. Complying with these unique requirements demands a meticulous approach from contract manufacturers to ensure full compliance with the specific regulations of the markets they serve. This aspect could potentially limit the expansion of the pharmaceutical CDMO market in the coming years.
What Questions Should You Ask before Buying a Market Research Report? • How is the ophthalmic drugs contract manufacturing market evolving? • What is driving and restraining the ophthalmic drugs contract manufacturing market? • How will each ophthalmic drugs contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033? • How will the market shares for each ophthalmic drugs contract manufacturing submarket develop from 2023 to 2033? • What will be the main driver for the overall market from 2023 to 2033? • Will leading ophthalmic drugs contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033? • Who are the leading players and what are their prospects over the forecast period? • How will the industry evolve during the period between 2023 and 2033? What are the implications of ophthalmic drugs contract manufacturing projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the ophthalmic drugs contract manufacturing market? • Where is the ophthalmic drugs contract manufacturing market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Ophthalmic Drugs Contract Manufacturing market today, and over the next 10 years: • Our 334-page report provides 122 tables, 174 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the ophthalmic drugs contract manufacturing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising ophthalmic drugs contract manufacturing prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America • U.S. • Canada
Europe • Germany • Spain • UK • France • Italy • Rest of Europe
Asia Pacific • China • Japan • India • Australia • South Korea • Rest of Asia Pacific
Latin America • Brazil • Mexico • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Ophthalmic Drugs Contract Manufacturing Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • Abbvie Inc. • Catalent Inc. • Eurofins Scientific • Glenmark Pharmaceuticals • Jubilant HollisterStier LLC • Laboratorios Salvat, S.A. • Lonza • Merck KGaA • Pillar5 Pharma • Recipharm • Siegfried Holding AG • Thermo Fisher Scientific Inc. • Unither Pharmaceuticals
Overall world revenue for Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033 in terms of value the market will surpass US$3,683.4 million in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033 report help you? In summary, our 330+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033 Market, with forecasts for mode of delivery, clinical trial phase, therapeutic area, end users and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Ophthalmic Drugs Contract Manufacturing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Ophthalmic Drugs Contract Manufacturing market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Buy our report today Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033: Forecasts by Product Type (API, FDFs), by Primary Packaging Type (Ampoules & Vials, Glass & Plastic Bottles, Ointment Tubes, Others), by Scale of Manufacturing (Preclinical, Clinical, Commercial), by Company Size (Small Sized, Mid Sized, Large Sized), by Indication (Age-Related Macular Degeneration, Glaucoma, Uveitis, Dry Eye Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview 1.1 Objectives of the Study 1.2 Introduction to Ophthalmic Drugs Contract Manufacturing Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report for? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 High cost of in-house drug development is likely to propel the market growth 3.2.1.2 Growing prevalence of ophthalmic disorders 3.2.1.3 Reduced overall cost and time to the market 3.2.1.4 Ease of Supply Chain Issues and Bandwidth to Focus on Core Competencies 3.2.2 Market Restraining Factors 3.2.2.1 Varying regulatory requirements across regions 3.2.2.2 Introduction of Serialization 3.2.3 Market Opportunities 3.2.3.1 Growth in Emerging Markets 3.2.3.2 Scalability and flexible production capacity 3.2.3.3 Specialized Services for Niche Markets and Late-Stage Customization 3.2.3.4 Process Improvement with better AI, e-Platforms, real time and remote tracing 3.3 COVID-19 Impact Analysis 3.4 Porter’s Five Forces Analysis 3.4.1 Bargaining Power of Suppliers (Medium) 3.4.2 Bargaining Power of Buyers (Medium to High) 3.4.3 Competitive Rivalry (High) 3.4.4 Threat from Substitutes (Medium) 3.4.5 Threat of New Entrants (High) 3.5 PEST Analysis 3.5.1 Political 3.5.2 Economical 3.5.3 Social 3.5.4 Technological
4 Ophthalmic Drugs Contract Manufacturing Market Analysis by Product Type 4.1 Key Findings 4.2 Product Type Segment: Market Attractiveness Index 4.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 4.4 APIs 4.4.1 Market Size by Region, 2023-2033 (US$ Million) 4.4.2 Market Share by Region, 2023 & 2033 (%) 4.5 FDFs 4.5.1 Market Size by Region, 2023-2033 (US$ Million) 4.5.2 Market Share by Region, 2023 & 2033 (%) 4.5.3 FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type
5 Ophthalmic Drugs Contract Manufacturing Market Analysis by Primary Packaging 5.1 Key Findings 5.2 Primary Packaging Segment: Market Attractiveness Index 5.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging 5.4 Ampoules & Vials 5.4.1 Market Size by Region, 2023-2033 (US$ Million) 5.4.2 Market Share by Region, 2023 & 2033 (%) 5.5 Glass & Plastic Bottles 5.5.1 Market Size by Region, 2023-2033 (US$ Million) 5.5.2 Market Share by Region, 2023 & 2033 (%) 5.6 Ointment Tubes 5.6.1 Market Size by Region, 2023-2033 (US$ Million) 5.6.2 Market Share by Region, 2023 & 2033 (%) 5.7 Others 5.7.1 Market Size by Region, 2023-2033 (US$ Million) 5.7.2 Market Share by Region, 2023 & 2033 (%)
6 Ophthalmic Drugs Contract Manufacturing Market Analysis by Scale of Manufacturing 6.1 Key Findings 6.2 Scale of Manufacturing Segment: Market Attractiveness Index 6.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing 6.4 Preclinical 6.4.1 Market Size by Region, 2023-2033 (US$ Million) 6.4.2 Market Share by Region, 2023 & 2033 (%) 6.5 Clinical 6.5.1 Market Size by Region, 2023-2033 (US$ Million) 6.5.2 Market Share by Region, 2023 & 2033 (%) 6.6 Commercial 6.6.1 Market Size by Region, 2023-2033 (US$ Million) 6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Ophthalmic Drugs Contract Manufacturing Market Analysis by Company Size 7.1 Key Findings 7.2 Company Size Segment: Market Attractiveness Index 7.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size 7.4 Small Size 7.4.1 Market Size by Region, 2023-2033 (US$ Million) 7.4.2 Market Share by Region, 2023 & 2033 (%) 7.5 Mid-Sized 7.5.1 Market Size by Region, 2023-2033 (US$ Million) 7.5.2 Market Share by Region, 2023 & 2033 (%) 7.6 Large Sized 7.6.1 Market Size by Region, 2023-2033 (US$ Million) 7.6.2 Market Share by Region, 2023 & 2033 (%)
8 Ophthalmic Drugs Contract Manufacturing Market Analysis by Indication 8.1 Key Findings 8.2 Indication Segment: Market Attractiveness Index 8.3 Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication 8.4 Age-Related Macular Degeneration 8.4.1 Market Size by Region, 2023-2033 (US$ Million) 8.4.2 Market Share by Region, 2023 & 2033 (%) 8.5 Glaucoma 8.5.1 Market Size by Region, 2023-2033 (US$ Million) 8.5.2 Market Share by Region, 2023 & 2033 (%) 8.6 Uveitis 8.6.1 Market Size by Region, 2023-2033 (US$ Million) 8.6.2 Market Share by Region, 2023 & 2033 (%) 8.7 Dry Eye Disease 8.7.1 Market Size by Region, 2023-2033 (US$ Million) 8.7.2 Market Share by Region, 2023 & 2033 (%) 8.8 Others 8.8.1 Market Size by Region, 2023-2033 (US$ Million) 8.8.2 Market Share by Region, 2023 & 2033 (%)
9 Ophthalmic Dug Contract Manufacturing Market Analysis by Region 9.1 Key Findings 9.2 Regional Market Size Estimation and Forecast
10 North America Ophthalmic Drugs Contract Manufacturing Market Analysis 10.1 Key Findings 10.2 North America Ophthalmic Drug Contract Manufacturing Market Attractiveness Index 10.3 North America Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million) 10.4 North America Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country 10.5 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 10.5.1 North America FDFs Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 10.6 North America Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging 10.7 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing 10.8 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size 10.9 North America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication 10.10 U.S. Ophthalmic Drugs Contract Manufacturing Market Analysis 10.11 Canada Ophthalmic Drugs Contract Manufacturing Market Analysis
11 Europe Ophthalmic Drugs Contract Manufacturing Market Analysis 11.1 Key Findings 11.2 Europe Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index 11.3 Europe Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million) 11.4 Europe Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country 11.5 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 11.5.1 Europe FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 11.6 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging 11.7 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing 11.8 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size 11.9 Europe Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication 11.10 Germany Ophthalmic Drugs Contract Manufacturing Market Analysis 11.11 UK Ophthalmic Drugs Contract Manufacturing Market Analysis 11.12 France Ophthalmic Drugs Contract Manufacturing Market Analysis 11.13 Italy Ophthalmic Drugs Contract Manufacturing Market Analysis 11.14 Spain Ophthalmic Drugs Contract Manufacturing Market Analysis 11.15 Rest of Europe Ophthalmic Drugs Contract Manufacturing Market Analysis
12 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Analysis 12.1 Key Findings 12.2 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index 12.3 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million) 12.4 Asia Pacific Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country 12.5 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 12.5.1 Asia Pacific FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 12.6 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging 12.7 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing 12.8 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size 12.9 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication 12.10 Japan Ophthalmic Drugs Contract Manufacturing Market Analysis 12.11 China Ophthalmic Drugs Contract Manufacturing Market Analysis 12.12 India Ophthalmic Drugs Contract Manufacturing Market Analysis 12.13 Australia Ophthalmic Drugs Contract Manufacturing Market Analysis 12.14 South Korea Ophthalmic Drugs Contract Manufacturing Market Analysis 12.15 Rest of Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Analysis
13 Latin America Ophthalmic Drugs Contract Manufacturing Market Analysis 13.1 Key Findings 13.2 Latin America Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index 13.3 Latin America Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million) 13.4 Latin America Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country 13.5 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 13.5.1 Latin America FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 13.6 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging 13.7 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing 13.8 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size 13.9 Latin America Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication 13.10 Brazil Ophthalmic Drugs Contract Manufacturing Market Analysis 13.11 Mexico Ophthalmic Drugs Contract Manufacturing Market Analysis 13.12 Rest of Latin America Ophthalmic Drugs Contract Manufacturing Market Analysis
14 MEA Ophthalmic Drugs Contract Manufacturing Market Analysis 14.1 Key Findings 14.2 MEA Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index 14.3 MEA Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million) 14.4 MEA Ophthalmic Drug Contract Manufacturing Market Size Estimation and Forecast by Country 14.5 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 14.5.1 MEA FDFs in Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Product Type 14.6 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Primary Packaging 14.7 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Scale of Manufacturing 14.8 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Company Size 14.9 MEA Ophthalmic Drugs Contract Manufacturing Market Size Estimation and Forecast by Indication 14.10 GCC Ophthalmic Drugs Contract Manufacturing Market Analysis 14.11 South Africa Ophthalmic Drugs Contract Manufacturing Market Analysis 14.12 Rest of MEA Ophthalmic drug contract manufacturing Market Analysis
15 Company Profiles 15.1 Competitive Landscape, 2022 15.2 Strategic Outlook 15.3 Lonza 15.3.1 Company Snapshot 15.3.2 Company Overview 15.3.3 Financial Analysis 15.3.3.1 Net Revenue, 2018-2022 15.3.3.2 R&D, 2018-2022 15.3.4 Services Offered 15.3.5 Strategic Outlook 15.4 Recipharm 15.4.1 Company Snapshot 15.4.2 Company Overview 15.4.3 Financial Analysis 15.4.3.1 Net Revenue, 2018-2022 15.4.4 Services Offered 15.4.5 Strategic Outlook 15.5 Catalent Inc. 15.5.1 Company Snapshot 15.5.2 Company Overview 15.5.3 Financial Analysis 15.5.3.1 Net Revenue, 2018-2022 15.5.3.2 R&D, 2018-2022 15.5.3.3 Regional Market Shares, 2022 15.5.4 Services Offered 15.5.5 Strategic Outlook 15.6 Eurofins Scientific 15.6.1 Company Snapshot 15.6.2 Company Overview 15.6.3 Financial Analysis 15.6.3.1 Net Revenue, 2018-2022 15.6.3.2 Regional Market Shares, 2022 15.6.4 Services Offered 15.6.5 Strategic Outlook 15.7 Thermo Fisher Scientific Inc. 15.7.1 Company Snapshot 15.7.2 Company Overview 15.7.3 Financial Analysis 15.7.3.1 Net Revenue, 2018-2022 15.7.3.2 Regional Market Shares, 2022 15.7.4 Services Offered 15.7.5 Strategic Outlook 15.8 Unither Pharmaceuticals 15.8.1 Company Snapshot 15.8.2 Company Overview 15.8.3 Services Offering 15.8.4 Strategic Outlook 15.9 Laboratorios Salvat, S.A. 15.9.1 Company Snapshot 15.9.2 Company Overview 15.9.3 Services Offered 15.9.4 Strategic Outlook 15.10 Siegfried Holding AG 15.10.1 Company Snapshot 15.10.2 Company Overview 15.10.3 Financial Analysis 15.10.3.1 Net Revenue, 2018-2022 15.10.3.2 R&D, 2018-2022 15.10.4 Services Offered 15.10.5 Strategic Outlook 15.11 Pillar5 Pharma 15.11.1 Company Snapshot 15.11.2 Company Overview 15.11.3 Service Offering 15.11.4 Strategic Outlook 15.12 Abbvie Inc. 15.12.1 Company Snapshot 15.12.2 Company Overview 15.12.3 Service Offerings 15.12.4 Strategic Outlook 15.13 Jubilant HollisterStier LLC 15.13.1 Company Snapshot 15.13.2 Company Overview 15.13.3 Service Offerings 15.13.4 Strategic Outlook 15.14 Glenmark Pharmaceuticals 15.14.1 Company Snapshot 15.14.2 Company Overview 15.14.3 Financial Analysis 15.14.3.1 Net Revenue, 2018-2022 15.14.3.2 R&D, 2021-2022 15.14.4 Product Benchmarking 15.15 Merck KGaA 15.15.1 Company Snapshot 15.15.2 Company Overview 15.15.3 Financial Analysis 15.15.3.1 Net Revenue, 2018-2022 15.15.3.2 R&D, 2018-2022 15.15.3.3 Regional Market Shares, 2022 15.15.4 Service Offerings 15.15.5 Strategic Outlook
16 Conclusion and Recommendations 16.1 Concluding Remarks from Visiongain 16.2 Recommendations for Market Players
List of Tables Table 1 Ophthalmic Drugs Contract Manufacturing Market Snapshot, 2023 & 2033 (US$ Million, CAGR %) Table 2 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery Table 3 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery Table 4 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery Table 5 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery Table 6 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR %) Table 7 APIs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 8 FDFs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 9 Global FDFs in Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR %) Table 10 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR%, CAGR %) Table 11 Ampoules & Vials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 12 Glass & Plastic Bottles Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 13 Ointment Tubes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 14 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 15 Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR%, CAGR %) Table 16 Pre-Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 17 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 18 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 19 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR %) Table 20 Small Sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 21 Mid-Sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 22 Large Sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 23 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR %) Table 24 Age-Related Macular Degeneration Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 25 Glaucoma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 26 Uveitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %) Table 27 Dry eye disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 28 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 29 Global Ophthalmic Drugs Contract Manufacturing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%) Table 30 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 31 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR %) Table 32 North America FDFs Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%) Table 33 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR%, CAGR %) Table 34 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR%, CAGR %) Table 35 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR %) Table 36 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR %) Table 37 U.S. Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 38 Canada Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 39 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 40 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%) Table 41 Europe FDFs in Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%) Table 42 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR%, CAGR%) Table 43 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR%, CAGR %) Table 44 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 45 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%) Table 46 Germany Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 47 UK Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 48 France Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 49 Italy Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 50 Spain Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 51 Rest of Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 52 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 53 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%) Table 54 Asia Pacific FDFs in Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR %) Table 55 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR%, CAGR%) Table 56 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR%, CAGR%) Table 57 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 58 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR %) Table 59 Japan Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 60 China Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 61 India Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 62 Australia Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 63 South Korea Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 64 Rest of Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 65 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %) Table 66 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR %) Table 67 Latin America FDFs in Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR %) Table 68 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR%, CAGR %) Table 69 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR%, CAGR %) Table 70 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR %) Table 71 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR %) Table 72 Brazil Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 73 Mexico Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 74 Rest of Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 75 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 76 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%) Table 77 MEA FDFs in Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%) Table 78 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR%, CAGR%) Table 79 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR%, CAGR%) Table 80 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 81 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%) Table 82 GCC Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 83 South Africa Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 84 Rest of MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 85 Strategic Outlook Table 86 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 87 Lonza: Services Offered Table 88 Lonza: Strategic Outlook Table 89 Recipharm: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 90 Recipharm: Product Benchmarking Table 91 Recipharm: Strategic Outlook Table 92 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 93 Catalent, Inc: Services Offered Table 94 Catalent, Inc: Strategic Outlook Table 95 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 96 Eurofins Scientific: Services Offered Table 97 Eurofins Scientific: Strategic Outlook Table 98 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 99 Thermo Fisher Scientific Inc: Services Offered Table 100 Thermo Fisher Scientific Inc: Strategic Outlook Table 101 Unither Pharmaceuticals: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment) Table 102 Unither Pharmaceuticals: Service Offerings Table 103 Unither Pharmaceuticals: Strategic Outlook Table 104 Laboratorios Salvat, S.A: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment) Table 105 Laboratorios Salvat, S.A: Services Offered Table 106 Laboratorios Salvat, S.A: Strategic Outlook Table 107 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 108 Siegfried Holding AG: Services Offered Table 109 Siegfried Holding AG: Strategic Outlook Table 110 Pillar5 Pharma: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment) Table 111 Pillar5 Pharma: Product Benchmarking Table 112 Pillar5 Pharma: Strategic Outlook Table 113 Abbvie Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 114 Abbvie Inc.: Service Offerings Table 115 Abbvie Inc.: Strategic Outlook Table 116 Jubilant HollisterStier: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 117 : Service Offerings Table 118 Jubilant HollisterStier: Strategic Outlook Table 119 Glenmark Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 120 Glenmark Pharmaceuticals: Product Benchmarking Table 121 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 122 Merck KGaA: Product Benchmarking Table 123 Merck KGaA: Strategic Outlook
List of Figures Figure 1 Ophthalmic Drugs Contract Manufacturing Market Segmentation Figure 2 Packaging Market by Product Type: Market Attractiveness Index Figure 3 Ophthalmic Drugs Contract Manufacturing Market Forecast by Packaging Type: Market Attractiveness Index Figure 4 Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing: Market Attractiveness Index Figure 5 Ophthalmic drugs contract manufacturing Market Forecast by Company Size: Market Attractiveness Index Figure 6 Ophthalmic drugs contract manufacturing Market Forecast by Indication: Market Attractiveness Index Figure 7 Ophthalmic Drugs Contract Manufacturing Market: Attractiveness Index by Region Figure 8 Ophthalmic drug contract manufacturing Market: Market Dynamics Figure 9 Ophthalmic Drugs Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %, CAGR%): “V” Shaped Recovery Figure 10 Ophthalmic Drugs Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %, CAGR %): “U” Shaped Recovery Figure 11 Ophthalmic Drugs Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 12 Ophthalmic Drugs Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %, CAGR %): “L” Shaped Recovery Figure 13 Ophthalmic Drugs Contract Manufacturing Market: Porter’s Five Forces Analysis Figure 14 Ophthalmic Drugs Contract Manufacturing Market: PEST Analysis Figure 15 Ophthalmic Drugs Contract Manufacturing Market by Product Type: Market Attractiveness Index Figure 16 Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %) Figure 17 Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Product Type, 2023, 2028, 2033 (%) Figure 18 APIs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 19 APIs Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 20 FDFs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 21 FDFs Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 22 Ophthalmic Drugs Contract Manufacturing Market by Primary Packaging: Market Attractiveness Index Figure 23 Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR %) Figure 24 Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Primary Packaging, 2023, 2028, 2033 (%) Figure 25 Ampoules & Vials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 26 Ampoules & Vials Segment Market Share Forecast by Region, 2022 & 2032 (%) Figure 27 Glass & Plastic Bottles Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 28 Glass & Plastic Bottles Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 29 Ointment Tubes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 30 Ointment Tubes Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 31 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 32 Others Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 33 Ophthalmic Drugs Contract Manufacturing Market by Scale of Manufacturing: Market Attractiveness Index Figure 34 Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR %) Figure 35 Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Scale of Manufacturing, 2023, 2028, 2033 (%) Figure 36 Pre Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 37 Pre Clinical Segment Market Share Forecast by Region, 2022 & 2032 (%) Figure 38 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 39 Clinical Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 40 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 41 Commercial Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 42 Ophthalmic Drugs Contract Manufacturing Market by Company Size: Market Attractiveness Index Figure 43 Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million) Figure 44 Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Company Size, 2023, 2028, 2033 (%) Figure 45 Small Sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 46 Small Sized Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 47 Mid Sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 48 Mid Sized Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 49 Large Sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 50 Large Sized Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 51 Ophthalmic Drugs Contract Manufacturing Market by Indication: Market Attractiveness Index Figure 52 Ophthalmic Drugs Contract Manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR %) Figure 53 Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Application, 2023, 2028, 2033 (%) Figure 54 Age-Related Macular Degeneration Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 55 Age-Related Macular Degeneration Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 56 Glaucoma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 57 Glaucoma Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 58 Uveitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 59 Uveitis Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 60 Dry Eye Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 61 Dry Eye Disease Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 62 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 63 Others Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 64 Ophthalmic Drugs Contract Manufacturing Market Forecast by Region 2023, 2033 (Revenue, CAGR%) Figure 65 Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Region 2023, 2028, 2033(%) Figure 66 Ophthalmic Drugs Contract Manufacturing Market by Region, 2023-2033 (US$ Million) Figure 67 North America Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index Figure 68 North America Ophthalmic Drugs Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million) Figure 69 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 70 North America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 71 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %) Figure 72 North America Ophthalmic drug contract manufacturing Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 73 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR %) Figure 74 North America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Primary Packaging, 2023 & 2033 (%) Figure 75 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million) Figure 76 North America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Scale of Manufacturing, 2023 & 2033 (%) Figure 77 North America Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 78 North America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 79 North America Ophthalmic drug contract manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR %) Figure 80 North America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Indication, 2023 & 2033 (%) Figure 81 U.S. Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 82 Canada Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 83 Europe Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index Figure 84 Europe Ophthalmic Drugs Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million) Figure 85 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 86 Europe Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 87 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %) Figure 88 Europe Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 89 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR %) Figure 90 Europe Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Primary Packaging, 2023 & 2033 (%) Figure 91 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR %) Figure 92 Europe Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Scale of Manufacturing, 2023 & 2033 (%) Figure 93 Europe Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 94 Europe Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 95 Europe Ophthalmic drug contract manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR %) Figure 96 Europe Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Indication, 2023 & 2033 (%) Figure 97 Germany Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 98 UK Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 99 France Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 100 Italy Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 101 Spain Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 102 Rest of Europe Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 103 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index Figure 104 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million) Figure 105 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 106 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 107 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %) Figure 108 Asia Pacific Ophthalmic drug contract manufacturing Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 109 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR %) Figure 110 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Primary Packaging, 2023 & 2033 (%) Figure 111 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR %) Figure 112 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Scale of Manufacturing, 2023 & 2033 (%) Figure 113 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 114 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 115 Asia Pacific Ophthalmic drug contract manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR %) Figure 116 Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Indication, 2023 & 2033 (%) Figure 117 Japan Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 118 China Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 119 India Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 120 Australia Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 121 South Korea Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 122 Rest of Asia Pacific Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 123 Latin America Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index Figure 124 Latin America Ophthalmic Drugs Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million) Figure 125 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 126 Latin America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 127 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %) Figure 128 Latin America Ophthalmic drug contract manufacturing Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 129 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR %) Figure 130 Latin America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Primary Packaging, 2023 & 2033 (%) Figure 131 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR %) Figure 132 Latin America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Scale of Manufacturing, 2023 & 2033 (%) Figure 133 Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 134 Latin America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 135 Latin America Ophthalmic drug contract manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR %) Figure 136 Latin America Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Indication, 2023 & 2033 (%) Figure 137 Brazil Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 138 Mexico Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 139 Rest of Latin America Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 140 MEA Ophthalmic Drugs Contract Manufacturing Market Attractiveness Index Figure 141 MEA Ophthalmic Drugs Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million) Figure 142 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 143 MEA Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 144 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %) Figure 145 MEA Ophthalmic drug contract manufacturing Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 146 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Primary Packaging, 2023-2033 (US$ Million, AGR %) Figure 147 MEA Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Primary Packaging, 2023 & 2033 (%) Figure 148 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Scale of Manufacturing, 2023-2033 (US$ Million, AGR %) Figure 149 MEA Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Scale of Manufacturing, 2023 & 2033 (%) Figure 150 MEA Ophthalmic Drugs Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 151 MEA Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 152 MEA Ophthalmic drug contract manufacturing Market Forecast by Indication, 2023-2033 (US$ Million, AGR %) Figure 153 MEA Ophthalmic Drugs Contract Manufacturing Market Share Forecast by Indication, 2023 & 2033 (%) Figure 154 GCC Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 155 South Africa Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 156 Rest of MEA Ophthalmic Drugs Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 157 Ophthalmic Drugs Contract Manufacturing Market: Company Share/Ranking, 2022 Figure 158 Lonza: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 159 Lonza: R&D, 2021-2022 (US$ Million, AGR%) Figure 160 Recipharm: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 161 Catalent, Inc: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 162 Catalent, Inc: R&D, 2018-2022 (US$ Million, AGR%) Figure 163 Catalent, Inc: Regional Market Shares, 2022 Figure 164 Eurofins Scientific: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 165 Eurofins Scientific: Regional Market Shares, 2022 Figure 166 Thermo Fisher Scientific Inc: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 167 Thermo Fisher Scientific Inc: Regional Market Shares, 2022 Figure 168 Siegfried Holding AG: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 169 Siegfried Holding AG: R&D, 2018-2022 (US$ Million, AGR%) Figure 170 Glenmark Pharmaceuticals: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 171 Glenmark Pharmaceuticals: R&D, 2021-2022 (US$ Million, AGR%) Figure 172 Merck KGaA: Net Revenue, 2018-2022 (US$ Million, AGR%) Figure 173 Merck KGaA: R&D, 2018-2022 (US$ Million, AGR%) Figure 174 Merck KGaA: Regional Market Shares, 2022
List of Companies Profiled in the report AbbVie Inc. Catalent Inc. Eurofins Scientific Glenmark Pharmaceuticals Jubilant HollisterStier LLC Laboratorios Salvat, S.A. Lonza Merck KGaA Pillar5 Pharma Recipharm Siegfried Holding AG Thermo Fisher Scientific Inc. Unither Pharmaceuticals
List of Other Companies Mentioned in the report Adare Pharmaceuticals Adragos Pharmaceutical AGC Biologics AGC Inc. Alcami Alexanderwerk Altasciences Ardena Avara Pharmaceutical Services Batavia Biosciences Bellwyck Pharma Services BioConnection Bionorica SE Biotranex Boehringer Ingelheim Bora Pharmaceuticals CARBOGEN AMCIS Celltrion Chong Kun Dang CJ Healthcare Crystal Formulation Services Daewoong Pharmaceutical Daicel Corporation Dalton Pharma Services Delpharm Dong-A ST Dr. Reddy's Laboratories Enzymatica Eurofarma Laboratorios Evonik Frontage Laboratories Fujifilm Diosynth Biotechnologies GC Green Cross Gilead Sciences GSK Hanmi LG Chem Lomapharm GmbH Lotte Biologics Luina Bio MaSTherCell Global PCI Pharma Services Pfizer, Inc. Pharmaterials Pionyr Immunotherapeutics Piramal Pharma Qotient Sciences QS Pharma ReiThera Resolution Spectra Systems Samsung Bioepis Sanofi Sartorius SeaView Research Seikagaku Servier Symphogen A/S Takeda Terumo Pharmaceutical Solutions Teva TriPharm Services UCB Uniao Quimica Farmaceutica Nacional Upperton Pharma Solutions Wockhardt Limited WuXi Biologics
List of Associations Mentioned in the Report American Autoimmune Related Diseases Association Inc. (AARDA) American Society of Health-System Pharmacists (ASHP) Centres for Medicare & Medicaid Services (CMS) Centre for Drug Evaluation and Research (CDER) European Marketing Authorization (EMA) Indian Drug Manufacturers Association (IDMA), Pharmaceutical Export Promotion Council (Pharmexcil) US Food & Drug Administration (USFDA)
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
